Prognostic role of microRNA-155 in patients with leukemia: A meta-analysis
Authors:
- 1 August 2018
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 483, 6-13
Abstract
No abstract availableKeywords
Funding Information
- Project for Shandong Medical and Health Science and Technology Plan Project (2015WS0193, 2014WS0067, 2014WS0065, 2016WS0523)
- Academy of Medical Sciences (JCSY201304, JCSY201405)
- Foundation for Outstanding Young Scientist in Shandong Province (2014BSC03013)
- Natural Science Foundation of Shandong Province (ZR2014HQ033)
- Innovation Project of Shandong Academy of Medical Sciences
This publication has 64 references indexed in Scilit:
- Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patientsJournal of Translational Medicine, 2013
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyBlood, 2010
- Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic miceBlood, 2009
- miR-155 gene: A typical multifunctional microRNABiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Inositol phosphatase SHIP1 is a primary target of miR-155Proceedings of the National Academy of Sciences, 2009
- Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosminProceedings of the National Academy of Sciences, 2008
- Requirement of bic/microRNA-155 for Normal Immune FunctionScience, 2007
- MicroRNA-155 is induced during the macrophage inflammatory responseProceedings of the National Academy of Sciences, 2007
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005